ANIK
Anika Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$20.40
+4.88%Oct 22, 2026, 20:01 UTC
Anika Therapeutics, Inc. announced that it will release its third-quarter 2026 financial results before the market opens on November 6, 2026, followed by a conference call at 8:30 a.m. ET.
Source:Jul 29, 2026, 14:05 UTC
Anika Therapeutics reported its second-quarter financial results for 2026, showing higher revenue, expanded gross margin, and the strongest adjusted EBITDA since 2020.
Source:Jul 14, 2026, 00:00 UTC
Anika Therapeutics, Inc. entered into a Fifth Amendment to its credit agreement, establishing a $50.0 million senior secured revolving line of credit with an option to increase to $100.0 million, maturing on July 10, 2031.